Predictive value of preoperative albumin-bilirubin score and other risk factors for short-term outcomes after open pancreatoduodenectomy

Table 2 Factors associated with postoperative complications (univariate logistic regression), n (%)

	No postoperative complications (n = 164)	Postoperative complications (n = 183)	OR (95%CI)	P value
Male gender	81 (49.4)	112 (61.2)	1.62 (1.05-2.48)	0.027
Age (yr), median (IQR)	67 (60.5-74.5)	69 (63-76)	1.01 (0.99-1.03)	0.383
BMI, median (IQR)	24.6 (22.0-27.8)	25.4 (22.8-29.0)	1.06 (1.01-1.12)	0.014
ASA score				0.0191
1	8 (4.9)	2 (1.1)
2	66 (40.2)	70 (38.3)
3	90 (54.9)	107 (58.5)
4	0 (0)	4 (2.2)
ALBI score	-2.6 (-3.0 to -2.1)	-2.6 (-3.0 to -1.9)	1.14 (0.84-1.56)	0.404
Operation type
PPPD	88 (53.7)	87 (47.5)	1
Whipple	76 (46.3)	96 (52.5)	1.28 (0.84-1.95)	0.255
Somatostatin use	82 (50)	103 (56.3)	1.29 (0.84-1.97)	0.242
Soft pancreatic texture	60 (41.7)	104 (63.8)	2.47 (1.56-3.91)	< 0.001
Blood loss (mL), median (IQR)	400 (250-500)	400 (300-600)	1.05 (0.99-1.10)	0.088
Pathology
Pancreatic carcinoma	95 (57.9)	75 (41.0)	0.50 (0.33-0.77)	0.002
Bile duct carcinoma	12 (7.3)	24 (13.1)	1.91 (0.92-3.96)	0.081
Duodenal carcinoma	1 (0.6)	8 (4.4)	7.45 (0.92-60.23)	0.060
Ampullary carcinoma	21 (12.8)	25 (13.7)	1.08 (0.58-2.01)	0.814
NET	12 (7.3)	15 (8.2)	1.13 (0.51-2.49)	0.760
IPMN	8 (4.9)	8 (4.4)	0.89 (0.33-2.43)	0.822

¹Likelihood ratio test.

OR: Odds ratio; IQR: Interquartile range; BMI: Body mass index; ALBI: Albumin-bilirubin; ASA score: American Society of Anesthesiologists score; PPPD: Pylorus-preserving pancreatoduodenectomy; NET: Neuroendocrine tumour; IPMN: Intraductal papillary mucinous neoplasm.